Latest Tech News

Stay updated with the latest in technology, AI, cybersecurity, and more

Filtered by: compound Clear Filter

My AI Had Fixed the Code Before I Saw It

Was this newsletter forwarded to you? Sign up to get it in your inbox. Before I opened my laptop, the code had reviewed itself. I launched GitHub expecting to dive into my usual routine—flag poorly named variables, trim excessive tests, and suggest simpler ways to handle errors. Instead, I found a few strong comments from Claude Code , the AI that writes and edits in my terminal: "Changed variable naming to match pattern from PR [pull request] #234, removed excessive test coverage per feedbac

Mark Zuckerberg Is Expanding His Secretive Hawaii Compound. Part of It Sits Atop a Burial Ground

As a child, Julian Ako would visit his maternal great-grandfather’s home near Pilaa Beach in Kauai, Hawaii, where he and his family would gather edible fungi that grow on kukui trees and collect seaweed and fish from the reef. For about a decade, that land has belonged to Meta CEO Mark Zuckerberg, who is constructing a massive compound at an estimated cost that exceeds $300 million. WIRED can now reveal that Zuckerberg’s property is atop a burial site: Ako’s great-grandmother and her brother we

Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs

Bad blood is brewing among some major players in the weight loss world. Novo Nordisk, the creator of Ozempic and Wegovy, cut short its partnership with telehealth company Hims & Hers Health Inc. over allegations that the latter is still trying to mass-market cheaper versions of the GLP-1 drugs. Bloomberg News reported the abrupt dissolution of the partnership Monday, just two months after it was struck. Novo claims that Hims is using “deceptive marketing” to widely sell compounded semaglutide t

Bioprospectors mine microbial genomes for antibiotic gold

In brief The discovery of penicillin nearly 100 years ago started a gold rush to find new antimicrobials. Scientists mined microscopic bacteria and fungi for compounds that could help fight off infection. But over time the rate of antimicrobial discoveries slowed to a crawl. Now, modern-day bioprospectors are using genomics, synthetic biology, and AI to dig deeper than they ever have before. A new golden age of antibiotics may be upon us, say some on the hunt, though getting a drug candidate int

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk's blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies such as Hims & Hers have been

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk's blockbuster weight loss drugs Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies like Hims & Hers have been pr